Skip to main content

Angiodynamic Inc (ANGO) Stock

Angiodynamic Inc Stock Details, Movements and Public Alerts

Stock Details

Angiodynamic Inc (ANGO), a prominent company in the healthcare sector within the medical instruments & supplies industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $10.33. Over the past 52 weeks, it has ranged between $5.83 and $13.50. This places the current price at 76.5% of its 52-week high and 77.2% above its 52-week low. The 14-day Relative Strength Index (RSI) stands at 59.57, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $9.74 by 6.06%. Similarly, it is above its 200-day moving average of $9.89 by 4.45%. The MACD histogram is -0.07, indicating bearish momentum (MACD Line: 0.26, Signal Line: 0.32). There are currently 5 active alerts set for ANGO by users.

Market Cap

$435.60M

52-Week High

$13.50

-23.48% from high

52-Week Low

$5.83

+77.19% from low

Avg Daily Volume

550,584

100-day average

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

96.15

PEG Ratio

1.87

Reasonably valued

Price to Book

2.38

EV/EBITDA

227.75

EPS (TTM)

-$0.83

Price to Sales

1.49

Beta

0.64

Less volatile than market

How is ANGO valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is ANGO's risk profile compared to the market?
With a beta of 0.64, Angiodynamic Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 2.38 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-11.60%

Operating Margin

-4.53%

Return on Equity

-17.50%

Return on Assets

-5.03%

Revenue Growth (YoY)

12.90%

Earnings Growth (YoY)

0.00%

How profitable and efficient is ANGO's business model?
Angiodynamic Inc achieves a profit margin of -11.60%, meaning it retains $-11.60 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -4.53% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -17.50% and ROA at -5.03%, the company achieves moderate returns on invested capital.
What are ANGO's recent growth trends?
Angiodynamic Inc's revenue grew by 12.90% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets.0 These growth metrics should be evaluated against MEDICAL INSTRUMENTS & SUPPLIES industry averages for proper context.

Company Size & Market

Shares Outstanding

40.63M

Book Value/Share

$4.46

Asset Type

Common Stock

What is ANGO's market capitalization and position?
Angiodynamic Inc has a market capitalization of $435.60M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 40.63M shares outstanding, the company's ownership is relatively concentrated. As a participant in the MEDICAL INSTRUMENTS & SUPPLIES industry, it competes with other firms in this sector.
How does ANGO's price compare to its book value?
Angiodynamic Inc's book value per share is $4.46, while the current stock price is $10.33, resulting in a price-to-book (P/B) ratio of 2.31. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$18.25

76.67% upside potential

Analyst Recommendations

No analyst ratings available

How reliable are analyst predictions for ANGO?
0 analysts cover ANGO with 0% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $18.25 implies 76.7% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on ANGO?
Current analyst recommendations:The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Sep 26, 2025, 04:12 AM

Earnings Dates

Upcoming Earnings

Q3

Oct 2, 2025

Est. EPS: $-0.12

In 2 days

Recent Earnings History

DateQuarterEstimated EPSActual EPSSurprise
Jul 15, 2025Q2$-0.12$-0.03+75.0%
Apr 2, 2025Q1$-0.13$0.03+123.1%
Jan 8, 2025Q4$-0.11$-0.04+63.6%
Oct 3, 2024Q3$-0.15$-0.11+26.7%
Jul 16, 2024Q2$-0.17$-0.06+64.7%
Apr 4, 2024Q1$-0.14$-0.16-14.3%
Jan 5, 2024Q4$-0.07$-0.05+28.6%
Oct 4, 2023Q3$-0.13$-0.12+7.7%

Technical Indicators

RSI (14-day)

59.57

Neutral

50-Day Moving Average

$9.74

6.06% above MA-50

200-Day Moving Average

$9.89

4.45% above MA-200

MACD Line

0.26

MACD Signal

0.32

MACD Histogram

-0.07

Bearish

What does ANGO's RSI value tell investors?
The RSI (Relative Strength Index) for ANGO is currently 59.57, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret ANGO's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.26 below the signal line at 0.32, with histogram at -0.07. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($9.74) is below the 200-day MA ($9.89), forming a death cross pattern that often warns of extended weakness. Price is currently above both MAs, confirming strength.

Indicators last updated: Sep 30, 2025, 12:42 AM

Active Alerts

Alert Condition
RSI Threshold Cross
Threshold
45
Created
Sep 29, 2025, 04:10 PM
Alert Condition
Price falls below
Threshold
$9.60
Created
Sep 26, 2025, 04:09 AM
Alert Condition
Price rises above
Threshold
$11.50
Created
Sep 26, 2025, 04:09 AM
Alert Condition
RSI Threshold Cross
Threshold
30
Created
Sep 26, 2025, 04:09 AM
Alert Condition
MA Breakout (Bearish)
Threshold
50 days
Created
Sep 26, 2025, 04:09 AM

Stay Ahead of the Market with Angiodynamic Inc Alerts

Set up price alerts for Angiodynamic Inc and get notified instantly when the price hits your target. Never miss an important price movement again.